Advicenne S.A. (ALDVI.PA)

EUR 1.73

(0.0%)

Operating Expenses Summary of Advicenne S.A.

  • Advicenne S.A.'s latest annual operating expenses in 2023 was 8.21 Million EUR , down -27.55% from previous year.
  • Advicenne S.A.'s latest quarterly operating expenses in 2024 Q1 was 2.69 Million EUR , up 37.24% from previous quarter.
  • Advicenne S.A. reported a annual operating expenses of 11.33 Million EUR in annual operating expenses 2022, down -19.92% from previous year.
  • Advicenne S.A. reported a annual operating expenses of 14.15 Million EUR in annual operating expenses 2021, down -7.52% from previous year.
  • Advicenne S.A. reported a quarterly operating expenses of 2.69 Million EUR for 2024 Q1, up 37.24% from previous quarter.
  • Advicenne S.A. reported a quarterly operating expenses of 2.07 Million EUR for 2023 Q1, down -66.04% from previous quarter.

Annual Operating Expenses Chart of Advicenne S.A. (2023 - 2014)

Created with Highcharts 11.1.0YearsOperating Expenses2014201520162017201820192020202120222023-5000000 EUR0 EUR5000000 EUR10000000 EUR15000000 EUR20000000 EUR

Historical Annual Operating Expenses of Advicenne S.A. (2023 - 2014)

Year Operating Expenses Operating Expenses Growth
2023 8.21 Million EUR -27.55%
2022 11.33 Million EUR -19.92%
2021 14.15 Million EUR -7.52%
2020 15.31 Million EUR 303.19%
2019 3.79 Million EUR 339.91%
2018 -1.58 Million EUR -188.1%
2017 1.79 Million EUR -46.16%
2016 3.33 Million EUR -4.93%
2015 3.51 Million EUR 71.36%
2014 2.04 Million EUR 0.0%

Peer Operating Expenses Comparison of Advicenne S.A.

Name Operating Expenses Operating Expenses Difference
ABIONYX Pharma SA 4.17 Million EUR -96.672%
ABIVAX Société Anonyme 127.37 Million EUR 93.551%
Adocia SA 15.62 Million EUR 47.437%
Aelis Farma SA 18.81 Million EUR 56.347%
Biophytis S.A. 14.33 Million EUR 42.685%
genOway Société anonyme 16.73 Million EUR 50.921%
IntegraGen SA 5.35 Million EUR -53.479%
Medesis Pharma S.A. 1.56 Million EUR -425.064%
Neovacs S.A. 10.34 Million EUR 20.578%
NFL Biosciences SA 4.37 Million EUR -87.799%
Plant Advanced Technologies SA 2.76 Million EUR -197.123%
Quantum Genomics Société Anonyme 1.71 Million EUR -378.182%
Sensorion SA 27.05 Million EUR 69.634%
Theranexus Société Anonyme 3 Million EUR -173.379%
TME Pharma N.V. 5.49 Million EUR -49.445%
Valbiotis SA 9.86 Million EUR 16.76%
TheraVet SA 1.64 Million EUR -399.601%
Valerio Therapeutics Société anonyme 20.32 Million EUR 59.572%
DBV Technologies S.A. 89.4 Million EUR 90.812%
Genfit S.A. 54.8 Million EUR 85.01%
GeNeuro SA 14.35 Million EUR 42.782%
Innate Pharma S.A. 64.57 Million EUR 87.277%
Inventiva S.A. 120.18 Million EUR 93.165%
MaaT Pharma SA 21.59 Million EUR 61.964%
MedinCell S.A. 32.92 Million EUR 75.047%
Nanobiotix S.A. 58.92 Million EUR 86.059%
OSE Immunotherapeutics SA 23.58 Million EUR 65.174%
Poxel S.A. 28.76 Million EUR 71.441%
GenSight Biologics S.A. 32.66 Million EUR 74.847%
Transgene SA 31.23 Million EUR 73.696%
Valneva SE 134.92 Million EUR 93.911%